Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

QIAGEN-sponsored Award Granted for Pioneering Work on Viral Infections and the Cell Biology of Protein Folding

Published: Friday, April 09, 2010
Last Updated: Friday, April 09, 2010
Bookmark and Share
The Finnish scientist Ari Helenius has received the Otto-Warburg-Medal of the German Society for Biochemistry and Molecular Biology.

Today the Finnish scientist Ari Helenius has received the Otto-Warburg-Medal of the German Society for Biochemistry and Molecular Biology (GBM). The medal is considered the highest German honor for biochemists and molecular biologists.

Helenius explored how viruses change the programming of their host cells to their own benefit. In doing so he also discovered basic principles of biological “quality control” for the folding and assembly of protein molecules. QIAGEN, leading provider of sample and assay technologies, exclusively sponsors the Otto-Warburg-Medal with a grant of 25 000 Euros. Helenius received the award today in Mosbach, Germany.

Viruses proliferate by entering living cells and replicating there – generally to the disadvantage of the infected cell. Professor Ari Helenius explored the molecular processes of how influenza viruses manipulate their host cells, in particular by studying the synthesis and folding of Hemagglutinin. This protein molecule is being built into the virus membrane.

Helenius discovered that the attacked cell not only produces more Hemagglutinin and transports it to the membrane surface – it also checks it with a quality control system, which is actually in place for normal host cell proteins. Only functional proteins that are folded accurately and have the right structure will be processed by this biochemical “sorting -machine”.

Special enzymes recognize misfolded proteins and then a sugar molecule is added as an attachment to them. Proteins having this marker cannot leave the endoplasmic reticulum, the location where they have been assembled. This testing of newly synthesized proteins is of vital importance: a faulty molecular quality control can be the cause for different diseases like cystic fibrosis and diabetes. The concepts developed by Ari Helenius are now textbook knowledge.

“Ari Helenius strongly influenced the cell biological research over decades and developed innovative experimental approaches,” says Prof. Nikolaus Pfanner, president of the GBM. „The far ranging concepts he developed based on these discoveries are commonly accepted today. A better understanding of viral infections and cellular quality control established by his work could disclose new therapeutic options in medicine in the near future.”

“We are excited to see the Otto-Warburg-Medal awarded to Ari Helenius, a pioneer of science whose findings have brought substantial advance in several disciplines,” says Dr. Thomas Schweins, Vice President Marketing and Strategy at QIAGEN. „As a provider of a multitude of solutions for sample preparation and analysis of DNA, RNA and proteins we are delighted that we can support Ari Helenius with this year’s award and in his future research.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

QIAGEN Partners with Exosome Diagnostics
Molecular testing of biofluids promises unprecedented access to gene mutations, gene expression signatures and expression levels without costly, invasive tissue biopsies.
Wednesday, July 24, 2013
Qiagen Subsidiary SABiosciences Expands RT2 Profiler PCR Arrays
Now more than 100 arrays for various disease areas available
Monday, July 05, 2010
Scientific News
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Stem Cells Rescue Patients from Mitochondrial Disease
A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.
Eco-Friendly Nanobullet to Battle Bacteria
Researchers have developed a method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells.
Blood Stem Cells in a Rush -- Velocity Determines Quality
Acceleration of the G1 phase transit during cell division makes human blood stem cells more powerful.
Modelling the Early Human Heart
Researchers have developed a template for growing beating cardiac tissue from stem cells, creating a system that could serve as a model for early heart development and as a drug-screening tool to make pregnancies safer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!